Literature DB >> 11210204

A review of the nonmedical use of ketamine: use, users and consequences.

K L Jansen1.   

Abstract

Ketamine is a dissociative anesthetic with an accepted place in human medicine. Ketamine also has psychedelic properties, and there has been a recent increase in nonmedical use linked with the growth of the "dance culture." This has attracted little comment in the formal literature but has been the subject of many reports in the media. Myths and misunderstandings are common. The psychedelic properties of ketamine have also led to its use as an adjunct to psychotherapy. This review is intended as a resource for the wide range of persons now requesting accurate information about the nonmedical use of ketamine. It accepts the current necessity of sometimes referring to anecdotal reports while seeking to encourage an increase in formal research. The review includes the history of ketamine, its growing role as a "dance drug," the sought-after effects (including the near-death experience) for which it is taken in a nonmedical context, how these are produced, common mental and physical adverse effects, and the ketamine model of schizophrenia.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11210204     DOI: 10.1080/02791072.2000.10400244

Source DB:  PubMed          Journal:  J Psychoactive Drugs        ISSN: 0279-1072


  43 in total

1.  ["Keta" (ketamine): from medication to drug abuse. Bio-psycho-social clinical profile of users and some therapy proposals].

Authors:  J Royo-Isach; M Magrané; M Domingo; B Cortés
Journal:  Aten Primaria       Date:  2004 Jul-Aug       Impact factor: 1.137

Review 2.  Ketamine enantiomers in the rapid and sustained antidepressant effects.

Authors:  John Muller; Sahana Pentyala; James Dilger; Srinivas Pentyala
Journal:  Ther Adv Psychopharmacol       Date:  2016-03-10

Review 3.  Chemical hemorrhagic cystitis: Diagnostic and therapeutic pitfalls (Review).

Authors:  Razvan-Cosmin Petca; Razvan-Ionut Popescu; Cristian Toma; Mihai Cristian Dumitrascu; Aida Petca; Florica Sandru; Calin Bogdan Chibelean
Journal:  Exp Ther Med       Date:  2021-04-14       Impact factor: 2.447

4.  Differences between adolescents and adults in the acute effects of PCP and ketamine and in sensitization following intermittent administration.

Authors:  Angelica Rocha; Nigel Hart; Keith A Trujillo
Journal:  Pharmacol Biochem Behav       Date:  2017-04-22       Impact factor: 3.533

5.  Antinociceptive effects, metabolism and disposition of ketamine in ponies under target-controlled drug infusion.

Authors:  M Knobloch; C J Portier; O L Levionnois; R Theurillat; W Thormann; C Spadavecchia; M Mevissen
Journal:  Toxicol Appl Pharmacol       Date:  2006-07-03       Impact factor: 4.219

Review 6.  Ketamine and Ketamine Metabolite Pharmacology: Insights into Therapeutic Mechanisms.

Authors:  Panos Zanos; Ruin Moaddel; Patrick J Morris; Lace M Riggs; Jaclyn N Highland; Polymnia Georgiou; Edna F R Pereira; Edson X Albuquerque; Craig J Thomas; Carlos A Zarate; Todd D Gould
Journal:  Pharmacol Rev       Date:  2018-07       Impact factor: 25.468

Review 7.  Clinical applications of hallucinogens: A review.

Authors:  Albert Garcia-Romeu; Brennan Kersgaard; Peter H Addy
Journal:  Exp Clin Psychopharmacol       Date:  2016-08       Impact factor: 3.157

8.  Ketamine beyond anesthesia: Antidepressant effects and abuse potential.

Authors:  Keith A Trujillo; Sergio D Iñiguez
Journal:  Behav Brain Res       Date:  2020-07-31       Impact factor: 3.332

Review 9.  Overlap in the neural circuitry and molecular mechanisms underlying ketamine abuse and its use as an antidepressant.

Authors:  Saurabh S Kokane; Ross J Armant; Carlos A Bolaños-Guzmán; Linda I Perrotti
Journal:  Behav Brain Res       Date:  2020-02-13       Impact factor: 3.332

10.  Secondary psychoses: an update.

Authors:  Matcheri S Keshavan; Yoshio Kaneko
Journal:  World Psychiatry       Date:  2013-02       Impact factor: 49.548

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.